Jen-Tsung Chen is currently a professor at the National University of Kaohsiung in Taiwan. He teaches cell biology, genomics, proteomics, medicinal plant biotechnology, and plant tissue culture. His research interests include bioactive compounds, chromatography techniques, in vitro culture, medicinal plants, phytochemicals, plant physiology, and plant biotechnology. He has published over 90 scientific papers and serves as an editorial board member for Plant Methods and Plant Nano Biology.

• Chapter 1 - Omics-guided intervention strategies in combatting SARS-CoV-2: Recent advancements and challengesChapter 2 - The application of computer-aided drug design methods for developing natural compounds-based therapeutics against SARS-CoV-2Chapter 3 - Therapeutic targets of host factors for potential COVID-19 treatmentsChapter 4 - Phytocompounds: A paradigm shift as therapeutics for COVID-19Chapter 5 - Flavonoids as potential therapeutic agents against the SARS-CoV-2 infection: An overviewChapter 6 - Antiviral activities of flavonoids against COVID-19 and other virus-causing ailmentsChapter 7 - Potential therapeutic effects of flavonoids against the COVID-19 infection: The mode of actionChapter 8 - Terpene and Terpenoid: Potent antiviral agents against SARS-CoV-2Chapter 9 - Phytonutrients and secondary metabolites to cease SARS-CoV-2 loopChapter 10 - Treatment strategies against COVID-19 using bioactive compounds and plant secondary metabolitesChapter 11 - The potential contribution of vitamin K as a nutraceutical to scale down the mortality rate of COVID-19Chapter 12 - Gastrointestinal Symptoms in COVID-19 patients: Prevention and TreatmentChapter 13 - Mechanisms and management options of liver injury in COVID19: A Review Chapter 14 - Marine species-derived bioactives against coronavirus diseaseChapter 15 - Potential bioactive compounds of Indian flora against SARS-CoV-2Chapter 16 - Natural product-derived active compounds for the management of COVID-19: A summary from IndochinaChapter 17 - Novel therapeutic strategy based on nanomedicine targeting thrombosis for SARSCoV-2 Chapter 18 - Nanomaterials in combating human coronavirus infectionsChapter 19 - Structural insights into drug targets from MERS, SARS-CoV, and SARS-CoV-2 and scope for phytochemicals as broad-spectrum anti-virals and immunomodulators.Chapter 20 - Precision phytochemicals for COVID-19-induced olfactory dysfunction

Jen-Tsung Chen is currently a professor at the National University of Kaohsiung in Taiwan. He teaches cell biology, genomics, proteomics, medicinal plant biotechnology, and plant tissue culture. His research interests include bioactive compounds, chromatography techniques, in vitro culture, medicinal plants, phytochemicals, plant physiology, and plant biotechnology. He has published over 90 scientific papers and serves as an editorial board member for Plant Methods and Plant Nano Biology.

• Chapter 1 - Omics-guided intervention strategies in combatting SARS-CoV-2: Recent advancements and challengesChapter 2 - The application of computer-aided drug design methods for developing natural compounds-based therapeutics against SARS-CoV-2Chapter 3 - Therapeutic targets of host factors for potential COVID-19 treatmentsChapter 4 - Phytocompounds: A paradigm shift as therapeutics for COVID-19Chapter 5 - Flavonoids as potential therapeutic agents against the SARS-CoV-2 infection: An overviewChapter 6 - Antiviral activities of flavonoids against COVID-19 and other virus-causing ailmentsChapter 7 - Potential therapeutic effects of flavonoids against the COVID-19 infection: The mode of actionChapter 8 - Terpene and Terpenoid: Potent antiviral agents against SARS-CoV-2Chapter 9 - Phytonutrients and secondary metabolites to cease SARS-CoV-2 loopChapter 10 - Treatment strategies against COVID-19 using bioactive compounds and plant secondary metabolitesChapter 11 - The potential contribution of vitamin K as a nutraceutical to scale down the mortality rate of COVID-19Chapter 12 - Gastrointestinal Symptoms in COVID-19 patients: Prevention and TreatmentChapter 13 - Mechanisms and management options of liver injury in COVID19: A Review Chapter 14 - Marine species-derived bioactives against coronavirus diseaseChapter 15 - Potential bioactive compounds of Indian flora against SARS-CoV-2Chapter 16 - Natural product-derived active compounds for the management of COVID-19: A summary from IndochinaChapter 17 - Novel therapeutic strategy based on nanomedicine targeting thrombosis for SARSCoV-2 Chapter 18 - Nanomaterials in combating human coronavirus infectionsChapter 19 - Structural insights into drug targets from MERS, SARS-CoV, and SARS-CoV-2 and scope for phytochemicals as broad-spectrum anti-virals and immunomodulators.Chapter 20 - Precision phytochemicals for COVID-19-induced olfactory dysfunction